Literature DB >> 26934858

Downregulation of long non-coding RNA TRIM52-AS1 functions as a tumor suppressor in renal cell carcinoma.

Zan Liu1, Hai-Yan Yan1, Shun-Yao Xia1, Cheng Zhang1, You-Cheng Xiu1.   

Abstract

Long non-coding RNAs (lncRNAs) are important regulators of gene expression, interacting with the major pathways of cell growth, proliferation, differentiation and survival. Alterations in the function of lncRNAs promote tumor formation, progression and metastasis. The purpose of the present study was to identify novel tumor suppressor lncRNAs, and elucidate their physiological function and mechanism in renal cell carcinoma (RCC). The results of the present study revealed that the expression of the lncRNA, TRIM52AS1, was downregulated in RCC, which was demonstrated using reverse transcription‑quantitative polymerase chain reaction analysis. Furthermore, the effects of TRIM52AS1 on proliferation, cell migration and apoptosis were analyzed using a wound scratch assay, a 3‑(4,5‑dimethylthiazol‑2yl)‑2,5‑diphenyl tetrazolium bromide assay and flow cytometric analysis, respectively. The overexpression of TRIM52AS1 using a synthesized vector significantly suppressed cell migration and proliferation, and induced apoptosis of the RCC cells in vitro, and interference of its expression led to the opposite effects. The present study was the first, to the best of our knowledge, to demonstrate that TRIM52AS1 functions as a tumor suppressor in RCC. Further investigation is required to elucidate the molecular mechanisms underlying the effects of TRIM52-AS1 in the development of RCC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26934858     DOI: 10.3892/mmr.2016.4908

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  10 in total

1.  Tripartite motif 52 (TRIM52) promotes proliferation, migration, and regulation of colon cancer cells associated with the NF-κB signaling pathway.

Authors:  Yanjiao Guo; Yiming Zhou; Xiaodong Gu; Jianbin Xiang
Journal:  J Gastrointest Oncol       Date:  2022-06

2.  Long Noncoding RNA HCG9 Promotes Osteosarcoma Progression through RAD51 by Acting as a ceRNA of miR-34b-3p.

Authors:  Lu Wang; ShuangQing Li; Lin Qi; Lin Ling
Journal:  Mediators Inflamm       Date:  2021-08-18       Impact factor: 4.529

Review 3.  Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications.

Authors:  Ming Li; Ying Wang; Liang Cheng; Wanting Niu; Guoan Zhao; Jithin K Raju; Jun Huo; Bin Wu; Bo Yin; Yongsheng Song; Renge Bu
Journal:  Oncotarget       Date:  2017-07-18

4.  Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.

Authors:  Jiang-Hui Zeng; Wei Lu; Liang Liang; Gang Chen; Hui-Hua Lan; Xiu-Yun Liang; Xu Zhu
Journal:  J Transl Med       Date:  2019-08-23       Impact factor: 5.531

5.  Long Non-Coding RNA TRIM52-AS1 Promotes Growth and Metastasis via miR-218-5p/ROBO1 in Hepatocellular Carcinoma.

Authors:  Yuanjun Liu; Yakun Wu; Shuang Liu; Yi Dai
Journal:  Cancer Manag Res       Date:  2021-01-22       Impact factor: 3.989

Review 6.  Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma.

Authors:  Zuozhang Yang; Xiaojuan Li; Yihao Yang; Zewei He; Xin Qu; Ya Zhang
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

7.  The downregulated long noncoding RNA DHRS4-AS1 is protumoral and associated with the prognosis of clear cell renal cell carcinoma.

Authors:  Changlin Wang; Gang Wang; Zijian Zhang; Zichun Wang; Minghua Ren; Xiaoxiong Wang; Haoming Li; Yipeng Yu; Jing Liu; Licheng Cai; Yong Li; Daming Zhang; Cheng Zhang
Journal:  Onco Targets Ther       Date:  2018-09-10       Impact factor: 4.147

8.  Integrated analysis of differentially expressed profiles and construction of a competing endogenous long non-coding RNA network in renal cell carcinoma.

Authors:  Qianwei Xing; Yeqing Huang; You Wu; Limin Ma; Bo Cai
Journal:  PeerJ       Date:  2018-07-17       Impact factor: 2.984

9.  Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma.

Authors:  Ren-Chao Zou; Zhi-Tian Shi; Shu-Feng Xiao; Yang Ke; Hao-Ran Tang; Tian-Gen Wu; Zhi-Tang Guo; Fan Ni; Sanqi An; Lin Wang
Journal:  PeerJ       Date:  2019-12-02       Impact factor: 2.984

10.  Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network.

Authors:  Shunqiang Nong; Xiaohao Chen; Zechen Wang; Guidan Xu; Wujun Wei; Bin Peng; Lü Zhou; Liuzhi Wei; Jingjie Zhao; Qiuju Wei; Yibin Deng; Lingzhang Meng
Journal:  Biomed Res Int       Date:  2021-10-15       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.